Comparison

rAAV-cFos-Cre-ERT2-P2A-EGFP (AAV2/B10)

Item no. BC-1168-AAV2/B10-2.0e12vg/ml-100ul
Manufacturer Brain Case
Amount 100 ul (Titer: ≥2.0e+12 vg/ml)
Category
Type Vector
Certificate GMP certified, ISO 9001:2015 Certified
Specific against other
Dry ice Yes
ECLASS 10.1 32160414
ECLASS 11.0 32160414
UNSPSC 41106600
Shipping condition Dry ice
Available
Manufacturer - Category
Recombinases / Cre
Shipping Temperature
Dry Ice
Storage Conditions
Store at -80°C
Serotype
AAV2/B10
Titer
≥2.0e+12 vg/ml
Promoter information
cFos
Functional gene
Cre-ERT2
Fluorescent marker
EGFP
Common serotype
AAV/9
Description
Cre-ERT2 is a modified version of the Cre recombinase enzyme that includes a ligand-binding domain from the estrogen receptor (ERT2). This modification allows for the conditional activation of Cre recombinase in response to the administration of tamoxifen (a synthetic estrogen).
Cell-specific (specific to each brain region, recommend the use of transgenic mice)
Immediate early genes (IEGs)

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 ul (Titer: ≥2.0e+12 vg/ml)
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close